Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Open accessThe DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is an endocrine-gynecology disorder affecting many women of childbearing age. Although a part of the involved mechanism in PCOS occurrence is discovered, the exact etiology and pathophysiology are not comprehensively understood yet. We searched PubMed for PCOS pathogenesis and management in this article and ClinicalTrials.gov for information on repurposed medications. All responsible factors behind PCOS were thoroughly evaluated. Furthermore, the complete information on PCOS commonly prescribed and repurposed medications is summarized through tables. Epigenetics, environmental toxicants, stress, diet as external factors, insulin resistance, hyperandrogenism, inflammation, oxidative stress, and obesity as internal factors were investigated. Lifestyle modifications and complementary and alternative medicines are preferred first-line therapy in many cases. Medications, including 3-hydroxy-3-methyl-3-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors, thiazolidinediones, sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, glucose-like peptide-1 receptor agonists, mucolytic agents, and some supplements have supporting data for being repurposed in PCOS. Since there are few completed clinical trials with a low population and mostly without results on PCOS repurposed medications, it would be helpful to do further research and run well-designed clinical trials on this subject. Moreover, understanding more about PCOS would be beneficial to find new medications implying the effect via the novel discovered routes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hyperandrogenism, hyperinsulinism and insulin resistance (IR) are the main drivers of clinical, metabolic and reproductive phenotypes of PCOS.”
From Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents (2023) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, the DAI has been developed as a more specific measure of adipose tissue dysfunction by combining WC, BMI, TG levels, and HDL-C [9,10,11].”
From Visceral and Dysfunctional Adiposity Indices as Predictors of Insulin Resistance and Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study (2025) · cites this paper as [10]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The VAI is an established marker of abdominal obesity and IR, integrating WC, triglyceride (TG) levels, and high-density lipoprotein cholesterol (HDL-C) to predict metabolic risk.”
From Visceral and Dysfunctional Adiposity Indices as Predictors of Insulin Resistance and Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study (2025) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083 · cited 3×
“In addition, it should be mentioned that studies on PCOS women approved the resemblance of their fatty tissue to men, and hence the effect of HA on adipose tissue dysfunction [8].”
BackgroundInfluentialRosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603 · cited 9×
“Hyperinsulinemia increases LH-binding sites and androgen-producing response to LH [44].”
BackgroundInfluentialChronic Low Grade Inflammation in Pathogenesis of PCOS
Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., Smolarczyk, R., & Meczekalski, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073789 · Cited by 680
Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00078 · Cited by 653
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557 · cited 1×
“One way androgen results in oxidative stress is by increasing MNC sensitivity to glucose and aggravating glucosestimulated oxidative stress [65].”
BackgroundPolycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity.
Zeng, X., Xie, Y.-J., Liu, Y.-T., Long, S.-L., & Mo, Z.-C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.003 · Cited by 525 · cited 9×
“It also plays a role in progesterone and estrogen production, ovulation, and decreased GnRH secretion [52].”
BackgroundInfluentialA novel and compact review on the role of oxidative stress in female reproduction
Lu, J., Wang, Z., Cao, J., Chen, Y., & Dong, Y. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0391-5 · Cited by 481 · cited 11×
“Taking SFAs induces inflammation by triggering an increase in TNF-α level in circulation and expressing a specific cytokine suppressor [36].”
BackgroundInfluentialIbáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463 · cited 7×
“This receptor hypomethylation leads to higher gene expression and sensitivity to LH [18,20].”
BackgroundInfluentialCharacteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Glueck, C. J., & Goldenberg, N. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.002 · Cited by 442 · cited 3×
“Excess abdominal fat is also responsible for the inflammatory condition [6,44,81].”
BackgroundCassar, S., Misso, M. L., Hopkins, W. G., Shaw, C. S., Teede, H. J., & Stepto, N. K. (2016) · Human Reproduction · doi:10.1093/humrep/dew243 · Cited by 415 · cited 1×
“On the other hand, hyperinsulinemia reduces hepatic SHBG [18,32,40,49,52,54–56], increasing free testosterone levels in blood [18,32,52,54,56].”
Background
Research works printed but not linked: 3
- Casadesús J. Noyer-Weidner M. Epigenetics Brenner’s Encyclopedia of Genetics 2nd ed. Maloy S. Hughes K. Academic Press San Diego, CA, USA 2013 500 503
- Jones L. Regan F. Endocrine Disrupting Chemicals Encyclopedia of Analytical Science 3rd ed. Worsfold P. Poole C. Townshend A. Miró M. Academic Press Oxford, UK 2019 31 38
- Zeind C.S. Carvalho M.G. Applied Therapeutics: The Clinical Use of Drugs Wolters Kluwer Health Philadelphia, PA, USA 2017
Cited by
Items 301–400 of 497
苍附导痰汤加减联合二甲双胍治疗多囊卵巢综合征伴胰岛素抵抗的Meta分析
郑, 博. (2025) · 健康文摘 · doi:10.61654/zzjkwz0601 · Cited by 1
Robeva, R. N., Andonova, S., Кirilov, G., Yordanova, I., Vandeva, S., Elenkova, A. P., Savov, A. S., & Todorov, T. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15124626 · Cited by 1
“Polycystic ovary syndrome (PCOS) is a heterogeneous condition affecting 1 in 10 women and is characterized by metabolic, reproductive, and psychological disturbances [1,2].”
Ye, J., Xiaoxia, Z., Cen, S., Zhang, B., He, H., Song, C., Ma, P., & Lin, H. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05689-9 · Cited by 1
Integrative approaches for the management of PCOS: A review
Joshi, A., Muthal, A., Namdeo, A. G., & Shinde, V. M. (2023) · International Journal of Herbal Medicine · doi:10.22271/flora.2023.v11.i2a.856 · Cited by 3
FETAL METABOLIC PROGRAMMING IN THE ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME
Silva, M. P. L. D., & Vargas, R. (2023) · Revista Contemporânea · doi:10.56083/rcv3n8-028 · Cited by 1
Genetics and Epigenetics of Polycystic Ovary Syndrome
Ponnam, S. P. G., & Paul, A. (2024) · Obstetrics and gynecology. · doi:10.5772/intechopen.113187 · Cited by 1
Nutritional Management of Polycystic Ovary Syndrome: Insights into Diet and Nutrition Strategies
Jan, B., Ahmad, S., Ibrahim, M., & Choudhary, B. (2024) · Natural Resources for Human Health · doi:10.53365/nrfhh/183616 · Cited by 2
“This excess androgen production is due to the raised levels of luteinizing hormone (LH) and insulin, which inturn stimulates the ovarian theca cells to produce androgens (Sadeghi et al., 2022).”
BackgroundZahoor, I., Singh, S., Sharma, N., Grewal, I. K., & Wani, S. N. (2023) · Pharmaceutical Sciences · doi:10.34172/ps.2023.24 · Cited by 2
“36-38 Cushing syndrome This endocrine disorder is severe and uncommon which is characterized as sustained elevated cortisol production.”
BackgroundNeghaddadgar, L., Mahmoudi, F., & Khazali, H. (2024) · Scientific Journal of Kurdistan University of Medical Sciences · doi:10.61186/sjku.28.6.1 · Cited by 1
Revolutionizing Infertility Management through Novel Peptide-based Targets
Kumar, V., & Doshi, G. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037304433240430144106 · Cited by 1
Harzif, A. K., Pratamasari, S. M. R., Rumapea, C. T. P., Ummah, N., Mutia, H. D., Nurbaeti, P., Puspawardani, A. R., & Wiweko, B. (2024) · Middle East Fertility Society Journal · doi:10.1186/s43043-024-00187-5 · Cited by 1
Best Practices for Identifying and Supporting Patients who Present with PCOS
Gabrielski, A. A., Daniels, S. L., Frey, K., & Land, A. (2024) · Nursing Clinics of North America · doi:10.1016/j.cnur.2024.08.007 · Cited by 1
NUTRITIONAL STRATEGIES IN POLYCYSTIC OVARY SYNDROME: A SYSTEMATIC REVIEW
Kaleeswari, G., & Rajalakshmi, D. S. (2024) · South Eastern European Journal of Public Health · doi:10.70135/seejph.vi.2733 · Cited by 1
Simão, D. O., Santos, A. V. M. P., Vieira, V. S., dos Reis, F. M., Cândido, A. L., Comim, F. V., Tosatti, J. A. G., & Gomes, K. B. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2502-8913 · Cited by 1
Kang, X., & Liu, L. (2025) · Journal of Medical Biochemistry · doi:10.5937/jomb0-53948 · Cited by 2
“…with a predilection for women of childbearing age, is clinically manifested as excessive androgen or characterised by clinical or biochemical manifestations, persistent anovulation, and polycystic changes in the ovaries (e.g., irregular menstrual cycles, infertility, hir-sutism, or acne) (1).”
Hao, Y., Liu, C.-M., Wang, N., Zhou, R., Wei, Y., Bai, X.-S., & Huang, X. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02115-6 · Cited by 1
“PCOS pathogenesis is complex and multifactorial, involving environmental and genetic factors [10].”
HIV/AIDS AND DRUG PREVENTION STRATEGIES FOR THE HIGHER EDUCATION CONTEXT
Mariyani, Istiarsyah, I., Ardiansyah, A., Maisura, Zikrullah, & Sari, M. (2024) · Jurnal Pengabdian Bangsa · doi:10.61992/jpb.v4i1.200 · Cited by 1
“One of the factors that influence drug abuse in adolescents is adolescent knowledge about drugs and the role of parents, in the study the respondents' knowledge was sufficient, respondents had never received counselling about drugs at school (Sadeghi et al., 2022; Ratnasari, 2015).”
What’s new on the horizon for polycystic ovarian syndrome? Exploring emerging drugs in phase II
D’Angelo, G., Ascione, M., Morra, I., Verrazzo, P., Bifulco, G., Giampaolino, P., & Corte, L. D. (2023) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2023.2260746 · Cited by 3
“In conclusion, while the research on Elagolix did not yield the desired outcomes, it has shed light on the challenges and potential directions in PCOS management [2].”
ResultZheng, Z., Wang, Y., & Liu, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3704976/v1 · Cited by 1
Абшекенова, А. Т., Бабаджанова, С. Д., & Карибаева, Ш. К. (2022) · Репродуктивная медицина · doi:10.37800/rm.2.2022.63-69
Rathod, D., Birle, R., Kayande, N. R., & Engla, G. (2022) · International Journal of Advanced Research in Science Communication and Technology · doi:10.48175/ijarsct-7527
محمد, س. ص. م. (2022) · المجلة التربوية لکلية التربية بسوهاج · doi:10.21608/edusohag.2022.272682
Role of Pathyapathya Kalpana in Polycystic Ovary Syndrome
Wankhede, P., & Chaudhari, P. (2023) · International journal of Indian medicine · doi:10.55552/ijim.2023.4401
“metabolism, affecting approximately 10% of women of reproductive age with onset manifesting as early as puberty, includes oligo/amenorrhoea, hirsutism, obesity and enlarged ovaries with multiple small cysts and thickened tunica.([1,2]) One out of three symptoms are consistent with the diagnosis”
BackgroundSÍNDROME DO OVÁRIO POLICÍSTICIO
Albernaz, L. M. B., & Oliveira, B. D. (2023) · doi:10.59290/978-65-6029-013-6.19
Raudhatun Nuzul, Z. A., Rahmayani, R., Meilina, R., & Jannah, M. (2023) · JOURNAL OF HEALTHCARE TECHNOLOGY AND MEDICINE · doi:10.33143/jhtm.v9i1.2840
Murta, A. L. R., Fernandes, M. E. M., Vieira, H. P. O., & Salles, T. M. D. A. (2023) · Amplla Editora eBooks · doi:10.51859/amplla.ama379.1123-3
A RELEVÂNCIA DA TERAPIA HORMONAL NO MANEJO DA MENOPAUSA
Silva, L. F., Gomes, J. L. D. S., Dorneles, J. A., & Paculdino, L. D. O. (2023) · Amplla Editora eBooks · doi:10.51859/amplla.ama379.1123-8
ASMA ASSOCIADA À OBESIDADE: UM FENÓTIPO DA ASMA AINDA NÃO COMPLETAMENTE ELUCIDADO
Felicio, P. T. G., Salgado, M. C. C., Strunk, M. A., & Júnior, E. A. (2023) · Amplla Editora eBooks · doi:10.51859/amplla.ama379.1123-2
O PAPEL DA SUPLEMENTAÇÃO DE VITAMINA D NA PERFORMANCE FÍSICA DE ATLETAS
Peixoto, J. G. D. C., Gonçalves, A. L. D., Xavier, L. A., & Cardoso, L. P. (2023) · Amplla Editora eBooks · doi:10.51859/amplla.ama379.1123-6
O IMPACTO DA SÍNDROME DO OVÁRIO POLICÍSTICO NO RISCO CARDIOVASCULAR
Santos, J. M. F., Santos, G. F., Nunes, B. C. M., & dos Reis, A. A. (2023) · Amplla Editora eBooks · doi:10.51859/amplla.ama379.1123-1
EVIDÊNCIAS CONTEMPORÂNEAS ACERCA DASÍNDROME DE SJOGREN
Mafra, A. F. R., de Araújo, I. N. B., Lopes, G. A., & Salgado, N. D. O. (2023) · Amplla Editora eBooks · doi:10.51859/amplla.ama379.1123-7
Gomes, J. L. D. S., Motta, H. A. P., Macedo, M. L. F. R., Dorneles, J. A., Leal, S. B., Paculdino, L. D. O., Soares, L. A., de Araújo, I. N. B., Campos, B. G., & da Silva, V. H. M. P. (2023) · Research Society and Development · doi:10.33448/rsd-v12i9.43306 · Cited by 3
Pruneti, C. A., Guidotti, S., & Cosentino, C. C. (2023) · Clinical Journal of Obstetrics and Gynecology · doi:10.29328/journal.cjog.1001142
DIETARY MANAGEMENT IN POLYCYSTIC OVARY SYNDROME: REVIEW
Caguana, P. B. T., Brito, J. K. O., Cabrera, J. S. M., Ávila, T. M. C., & Montesdeoca, A. A. Q. (2023) · EPRA International Journal of Multidisciplinary Research (IJMR) · doi:10.36713/epra14451 · Cited by 1
Beigh, S., Jabbar, A., Ayedh, S., Mohamed, S., Fahad, N., Abouhussien, R. M., & Nour, L. A. E. M. (2023) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/23.3.75-86
Chen, X., Zhang, W., Ma, Y., Chen, Y., & Xu, B. (2023) · Research Square · doi:10.21203/rs.3.rs-3497666/v1
Dietary advanced glycation end products (AGE) and women's infertility
Çelik, E., & Akdevelıoğlu, Y. (2023) · Current Perspectives on Health Sciences · doi:10.58208/cphs.1355248 · Cited by 1
Development of Research on the Etiology and Pathogenesis of Polycystic Ovary Syndrome
Wei, G., Wang, M., Yang, Y., & He, F. (2023) · Current Research in Medical Sciences · doi:10.56397/crms.2023.12.05
Sіusіuka, V. G., Sergienko, M. Y., Мakarchuk, O. I., Shevchenko, A. О., & Deinichenko, O. V. (2023) · Reproductive health of woman · doi:10.30841/2708-8731.6.2023.289991 · Cited by 3
Successful Management of Infertility due to PCOS Using an Ayurvedic Regimen
Sharma, S., Sanjyal, B., Pushpalatha, B., & Bharathi, K. (2023) · AYUSHDHARA · doi:10.47070/ayushdhara.v10i5.1350
Ren, Y., Liu, C., Li, X., Xie, F., Yu, X., Liu, S., Zhan, X., Liang, R., & Ding, Z. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4639313
An Overview: Polycystic Ovary Syndrome and Related Future Methods
-, S. Y. P., -, K. B., & -, R. O. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i06.10355
Mandal, S., Begum, R. F., Vellapandian, C., & Mohan, S. (2024) · Current Biotechnology · doi:10.2174/0122115501283971231226112856 · Cited by 1
A review on polyherbal and supplemental approach to treat Polycystic Ovarian Syndrome
Priya, & Rana, S. (2023) · Research in Pharmacy · doi:10.25081/rip.2023.v13.8683 · Cited by 3
“A PCOS diagnosis may be confirmed if at least two clinical or biochemical signs of hyperandrogenism, ovulatory dysfunction, or polycystic ovaries are present during an ultrasound (Sadeghi et al., 2022).”
BackgroundOgunlakin, A. D., Ojo, O. A., Osagie, P. O., Ubogu, O., Adegoke, A. A., & Ogunlakin, O. A. (2024) · Comparative Clinical Pathology · doi:10.1007/s00580-024-03555-9
“Genetics, neuroendocrine factors, environmental and lifestyle factors, and obesity are among the risk factors that predispose women to PCOS (Bulsara et al. 2021; Sadeghi et al. 2022).”
Síndrome de ovario poliquístico, el riesgo cardiovascular olvidado
Corredor-Rengifo, D., Pérez, T. B., Martinez, C. A. G., & Abreu-Lomba, A. (2023) · Interdisciplinary Journal of Epidemiology and Public Health · doi:10.18041/2665-427x/ijeph.1.10262
Fialho, Z. A., Frazão, M. D. A., Costa, T. P., Silva, S. T. D. C., Filho, M. Â. I. B., Paes, A. H. D. C. M., SILVA, I. G. D. M. E., Lopes, G. S. D. F. A., Prestes, G. R., & Andrade, C. D. J. B. B. V. (2024) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v5i4.5094
Saad, M. H. M., Wafa, Y., El-garhy, I. M. T., & Monem, M. A. E. (2023) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.58675/2682-339x.2135
Research Progress on Chronic Inflammation and Polycystic Ovary Syndrome and Related Treatments
王, 明. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441190
Polikistik Over Sendromunda Besinlerle Alınan İleri Glikasyon Son Ürünlerinin Rolü
Özdemir, M., & Bilgiç, P. (2024) · İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi · doi:10.38079/igusabder.1327059
Causes of Polycystic Ovarian Syndrome
Panda, S., Das, R., Konar, L., & Singh, M. (2024) · Obstetrics and gynecology. · doi:10.5772/intechopen.113877
Treatment challenges in oxidative stress, metabolic, and reproductive disorders
Syed, F. Z., Ihsan, M. T., & Rehman, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18807-7.00017-x
Prevalence Of Skin Manifestations In Patients With Polycystic Ovarian Syndrome
Naveed, T., Kiyani, A. A., Kausar, S., Naheed, A., Khan, D., & Malik, S. S. (2024) · Journal of Rawalpindi Medical College · doi:10.37939/jrmc.v28i1.2373
Nature's Remedy: Exploring Herbal Treatments for Polycystic Ovarian Syndrome
Attri, M., Raghav, A., & Chaudhary, H. (2024) · Current Nutraceuticals · doi:10.2174/0126659786282036240503112128 · Cited by 1
Essa, Z. M., AL-Qarawy, A. K. M., & Mohammed, A. K. (2024) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.30699/jogcr.9.3.340
de Lima, A. V. R., Amantéa, G. F. G., Cardoso, J. M. D. O., Pereira, L. M. D. O., & Silva, D. R. G. (2024) · Revista Contemporânea · doi:10.56083/rcv4n6-107
Ginecologia e Obstetrícia - Edição XI
FREITAS, G. B. L. D., COSTA, A. C. A., & SOARES, A. H. D. M. (2024) · doi:10.59290/978-65-6029-123-2
SÍNDROME DO OVÁRIO POLICÍSTICO: O QUE HÁ DE MAIS RECENTE NA LITERATURA
FRAGA, A. M. D., da Silva, A. S. M., MATTER, D. D. C., Pasini, I. S., KNOBLOCH, J. G., CARDORO, J. C., BARP, L. P., KOLLET, M. E. C., RASCH, O. R., SANTOS, P. H. C. D., et al. (2024) · doi:10.59290/978-65-6029-130-0.19
Pereira, F. F. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2024.tde-10062024-093326
Roy, M., Mazumder, R., Singh, N., Bhardwaj, S., Mishra, R., Mishra, R., & Kumar, B. (2024) · Current Drug Therapy · doi:10.2174/0115748855313334240827071434
Gaudette, L. E., Codier, L., & Garcia‐Albea, V. (2024) · Journal of the Dermatology Nurses’ Association · doi:10.1097/jdn.0000000000000807
Abdelwahab, S. A., Khamis, N. H., Rifaai, R. A., El‐Tahawy, N. F. G., & Ibrahim, R. (2024) · The Egyptian Journal of Histology · doi:10.21608/ejh.2024.294988.2083
Sharma, P., Mittal, P., & Arya, G. C. (2024) · Current Analytical Chemistry · doi:10.2174/0115734110312022240903060337
POLICISTINIŲ KIAUŠIDŽIŲ SINDROMAS: GYDYMO GALIMYBĖS
Pilkionytė, E. (2024) · Health Sciences · doi:10.35988/sm-hs.2024.293
Polycystic Ovary Syndrome: A “Perfect Example” of “Imperfection” in the Metabolic Health
Patra, S. (2024) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_23_24
Psoríase: abordagem de suas manifestações clínicas e terapêuticas disponíveis
Koch, T. B., de Oliveira, M. G., de Souza, L. F., & Aguiar, B. S. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5436291.1-3
Avanços em cirurgia robótica: aplicações e resultados em procedimentos abdominais
Azeredo, Á. L. M., de Almeida, L. F., Carnevale, G. D. F., & Machado, C. W. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5436291.1-11
Roscoe, M. M., Alves, M. T. S. V., Assunção, L. I. S., & Chaves, E. A. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5436291.1-6
Doenças oculares relacionadas ao uso excessivo de dispositivos eletrônicos
Camacho, S. A. H., Gonçalves, D. D., Gomes, M. G. G., & Bragatto, M. G. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5436291.1-10
Especialidades médicas - Volume 1
Penna, L. M. R., Koch, T. B., Roscoe, M. M., & Camacho, S. A. H. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5436291
Abordagens em Cirurgia Minimamente Invasiva para Doenças Abdominais
Lemes, V. B., Bastos, A. C. F. D. C., Messias, A. L. M., & Azevedo, G. O. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5436291.1-1
Campos, M. O. D. F., Andrade, J. F., & de Sá, C. T. (2024) · Editora Pascal LTDA eBooks · doi:10.29327/5436291.1-12
Khadir, F. K., Alsahaf, D. M., & Ajeed, A. M. (2024) · ACTA Pharmaceutica Sciencia · doi:10.23893/1307-2080.aps6249
El síndrome de Stein Leventhal
Zamora-Vargas, C. S., Carrión-Muso, Á. D., Cadena-Quishpe, A. M., & Ramos-Villacís, R. A. (2024) · Revista Arbitrada Interdisciplinaria de Ciencias de la Salud Salud y Vida · doi:10.35381/s.v.v8i2.4120
Derouiche, S., Kherraz, M., Chekima, N., & Allahoum, R. (2024) · Journal of Medical Research and Reviews · doi:10.5455/jmrr.20240809073855
PRZYBYLSKI, V. D. S., CARRARO, M., PESSUTO, G. G., SANTOS, M. M. D., LIMA, C. K. D., ROCHA, I. L. D. D., AZEVEDO, L. O. D., QUINES, M. E. D. F., Vidal, J. R., & OLIVEIRA, G. D. V. (2024) · doi:10.59290/978-65-6029-178-2.5
Imamura, D. U., Quinaud, F. A., Starling, I. C., Schumann, L. R., & Foffano, T. C. S. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n9-235
Metabolic syndrome in adolescents with mental disorders: diagnostics, prevention and treatment
Prusova, Т. I., Lepik, O. V., Kosterin, D. N., Yakovleva, Y. A., & Popov, M. Y. (2024) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2024-1039 · Cited by 1
Shah, S., Sharma, D. A., Ojha, S., & Debnath, M. (2024) · Journal of Datta Meghe Institute of Medical Sciences University · doi:10.4103/jdmimsu.jdmimsu_544_24
Research Progress on Polycystic Ovary Syndrome and Epigenetic DNA Methylation Regulation
蔡, 灵. (2025) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2025.151022
Tunjungseto, A., Iffatunnisa, F., Pratiwi, I. W., Muhyiddin, A. A. A., Ahsan, F., & Santoso, B. I. (2025) · BIO Web of Conferences · doi:10.1051/bioconf/202515402003
Oza, S., Bhatt, V., Chaudhary, P., & Chandel, D. (2025) · Gynäkologie in der Praxis · doi:10.1007/s41974-025-00355-z
To Explore the Mechanism of PCOS with Osteoporosis from the Perspective of Abnormal Bone Metabolism
贾, 夕. (2025) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2025.41124
Mohammed, B., & Surendran, P. (2025) · Journal of Hearing Science · doi:10.17430/jhs/194800
HIPERANDROGENISMO: MANIFESTAÇÕES CLÍNICAS, DESAFIOS DIAGNÓSTICOS E ABORDAGENS TERAPÊUTICAS
MARTINS, A. C. S., Duarte, A. C. V. D. A., Costa, A. M., OLIVEIRA, A. L. P. D., CRISTINO, E. M. C., ARAGÃO, F. V., SOUZA, Í. S., MORORÓ, I. J. M. E., VASCONCELOS, L. D. D. H., CARNEIRO, M. I. L., et al. (2025) · Editora Pasteur eBooks · doi:10.59290/978-65-6029-230-7.9
Polycystic Ovary Syndrome: Etiopathogenic and Diagnostic Advances
Ongoth, F. E. M., Buambo, J. R. G., Mbamognoua, N. G. A., Mayanda, R. L., Okoumou-Moko, A., Ornella, M. Y. D., Ekoundzola, J. R., Nkoua, S. E., Bouénizabila, E., & Itoua, C. (2025) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2025.154005 · Cited by 2
Zhao, S. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2025.au22999
Balancing Hormones and Skin Health: A Focus on Oral Contraceptives in Dermatology
(2025) · La Prensa Medica · doi:10.47275/2953-4763-443
Exploring metabolomic biomarkers using mass spectrometry techniques
COATES, K. (2025) · Cronfa (Swansea University) · doi:10.23889/suthesis.69791
Relação de Sop e Distúrbios Endócrinos com Menarca Precoce
Krüger, A., Reimer, J. P., da Conceição, N. B. T., Schwartz, L., Pinto, L. H., & de Lima, D. D. (2025) · Saúde Coletiva (Barueri) · doi:10.36489/saudecoletiva.2025v15i97p16028-16039
Asociación del síndrome de ovario poliquístico e hígado graso en mujeres: revisión de la literatura
Vergel, D. C. A., & Quintero, C. Y. S. (2025) · Revista Colombiana de Gastroenterología · doi:10.22516/25007440.1238 · Cited by 1
Hernández, Y. V., Mata, L. Y. S., Cervantes‐Elizarrarás, A., Ariza‐Ortega, J. A., & Delgado‐Olivares, L. (2025) · Con-Ciencia Boletín Científico de la Escuela Preparatoria No 3 · doi:10.29057/prepa3.v12i24.14868
Being Overweight: Impact on Disease Conditions
Shanmugham, D., Kabilan, V. R., Nagarajan, P., Gayathiri, E., & Kannan, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-32047-7_38-1
Gul, E., Sultana, S., Tanvir, S., & Chaudhry, S. (2025) · Cureus · doi:10.7759/cureus.87922 · Cited by 2
“DHEA is a noninvasive, accessible, and low-risk adjunctive treatment for women with ROS, an often-refractory condition where current treatments rarely yield an adequate response [17].”
MECHANISMS OF INTERRELATIONSHIP BETWEEN OBESITY AND DEVELOPMENT OF POLYCYSTIC OVARY SYNDROME
Ткаченко, С. С., Родинський, О. Г., & Reshetnikova, Y. (2025) · Bulletin of Problems Biology and Medicine · doi:10.29254/2077-4214-2025-2-177-121-129
Guo, Q., Zhou, Y., Li, L., Chen, X., & Sun, L. T. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2530571
“Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women [1,2].”
Plant-based approaches in the management of polycystic ovary syndrome: A review
Patel, M., Jujara, F., Panchal, J., Patel, N., Mehetre, J., & Kumar, V. (2025) · Journal of Pharmacognosy and Phytochemistry · doi:10.22271/phyto.2025.v14.i4d.15476
Siwi, M. A. A., & Firdausi, M. R. (2025) · Reslaj Religion Education Social Laa Roiba Journal · doi:10.47467/reslaj.v7i8.9745
Metadata
- Authors
- Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M.
- Affiliations
- Pharmaceutical Sciences Research Center (IR)
- Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
- University of Medicine and Pharmacy of Craiova (RO)
- Personalized Medicine Research Center (IR)
- University of Crete (GR)
- Corresponding author
- Abdollahi, Mohammad
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-06
- Volume
- 23
- Issue
- 2
- Pages
- 583
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8775814
- OpenAlex
- W4205636865
- Cited by
- 445
- References
- 106
- Citations by year
- 2026: 68 · 2025: 136 · 2024: 133 · 2023: 90 · 2022: 18
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, PCOS pathogenesis, drug repurposing, insulin resistance, hyperandrogenism, oxidative stress, inflammation, obesity, epigenetics, environmental toxins, stress, diet, statins, thiazolidinediones, SGLT2 inhibitors, DPP-4 inhibitors, GLP-1 receptor agonists, mucolytic agents, lifestyle modification, complementary and alternative medicine
- MeSH terms
- Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Disease Management, Drug Repositioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.